Subtopic Deep Dive

NADPH Oxidase NOX Family in Vascular ROS
Research Guide

What is NADPH Oxidase NOX Family in Vascular ROS?

NADPH oxidase (NOX) family enzymes (NOX1-5, DUOX) generate reactive oxygen species (ROS) in vascular endothelium and smooth muscle cells, influencing nitric oxide signaling and endothelin-mediated vasoconstriction.

NOX isoforms serve as primary ROS sources in vascular cells, activated by agonists like angiotensin II and endothelin. They promote oxidative stress that impairs NO bioavailability and drives vascular dysfunction (Madamanchi et al., 2004; 1566 citations). Over 20 papers detail NOX roles in hypertension and endothelial pathology (Lassègue et al., 2012; 750 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

NOX-derived ROS reduce NO bioavailability, exacerbating hypertension and diabetes-induced vascular remodeling (Paravicini and Touyz, 2008; 692 citations). In smooth muscle, NOX2 and NOX4 activation by endothelin enhances contraction and inflammation (Touyz et al., 2018; 644 citations). Inhibitors targeting NOX enzymes mitigate oxidative damage in cardiovascular diseases (Heumüller et al., 2007; 726 citations), informing therapies for atherosclerosis and heart failure (Lassègue et al., 2012).

Key Research Challenges

NOX Isoform Specificity

Distinguishing roles of NOX1, NOX2, NOX4, and NOX5 in endothelium versus smooth muscle remains difficult due to overlapping expression. Genetic models reveal isoform-specific contributions to ROS in hypertension (Lassègue et al., 2012). Selective inhibitors are needed beyond apocynin, which acts as an antioxidant (Heumüller et al., 2007).

ROS-NO Crosstalk Mechanisms

Superoxide from NOX inactivates NO, but spatiotemporal dynamics in vessels are unclear. Endothelial NOX2 upregulation impairs vasodilation in oxidative stress (Higashi et al., 2009). Quantifying this interplay requires advanced imaging (Madamanchi et al., 2004).

Therapeutic NOX Inhibition

Apocynin fails as a specific NOX inhibitor, complicating clinical translation (Heumüller et al., 2007). NOX inhibitors must balance ROS signaling benefits against pathology without toxicity (Panday et al., 2014). Trials in hypertension models show promise but need isoform targeting (Paravicini and Touyz, 2008).

Essential Papers

1.

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Celia Andrés, José Manuel Pérez de la Lastra, Francisco J. Plou et al. · 2021 · International Journal of Molecular Sciences · 2.3K citations

Living species are continuously subjected to all extrinsic forms of reactive oxidants and others that are produced endogenously. There is extensive literature on the generation and effects of react...

2.

Oxidative Stress and Vascular Disease

Nageswara R. Madamanchi, Aleksandr E. Vendrov, Marschall S. Runge · 2004 · Arteriosclerosis Thrombosis and Vascular Biology · 1.6K citations

Growing evidence indicates that chronic and acute overproduction of reactive oxygen species (ROS) under pathophysiologic conditions is integral in the development of cardiovascular diseases (CVD). ...

3.

NADPH oxidases: an overview from structure to innate immunity-associated pathologies

Arvind Panday, Malaya K. Sahoo, Diana Osorio et al. · 2014 · Cellular and Molecular Immunology · 900 citations

4.

Endothelial Function and Oxidative Stress in Cardiovascular Diseases

Yukihito Higashi, Kensuke Noma, Masao Yoshizumi et al. · 2009 · Circulation Journal · 774 citations

The vascular endothelium is involved in the release of various vasodilators, including nitric oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factor, as well as vasoconstrictors. N...

5.

Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System

Bernard Lassègue, Alejandra San Martín, Kathy K. Griendling · 2012 · Circulation Research · 750 citations

atherosclerosis, hypertension, cardiac hypertrophy and remodeling, angiogenesis and collateral formation, stroke, and heart failure. In this review, we discuss in detail the biochemistry of Nox enz...

6.

Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details

Richard L. Auten, Jonathan M. Davis · 2009 · Pediatric Research · 743 citations

7.

Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant

Sabine Heumüller, Sven Wind, Eduardo Barbosa‐Sicard et al. · 2007 · Hypertension · 726 citations

A large body of literature suggest that vascular reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases are important sources of reactive oxygen species. Many studies, however, relied...

Reading Guide

Foundational Papers

Start with Madamanchi et al. (2004; 1566 citations) for NOX-ROS in vascular disease overview, then Lassègue et al. (2012; 750 citations) for isoform biochemistry in endothelium and smooth muscle.

Recent Advances

Touyz et al. (2018; 644 citations) covers NOX in hypertensive smooth muscle contraction; Andrés et al. (2021; 2321 citations) details ROS chemistry impacts.

Core Methods

Superoxide detection (lucigenin, dihydroethidium), siRNA knockdowns for isoforms, and NADPH oxidase assays quantify activity (Panday et al., 2014; Heumüller et al., 2007).

How PapersFlow Helps You Research NADPH Oxidase NOX Family in Vascular ROS

Discover & Search

Research Agent uses searchPapers('NOX isoforms vascular endothelium ROS NO crosstalk') to find Lassègue et al. (2012), then citationGraph reveals 750+ downstream papers on hypertension. exaSearch uncovers recent inhibitor studies; findSimilarPapers expands to Touyz et al. (2018) for smooth muscle contraction.

Analyze & Verify

Analysis Agent applies readPaperContent on Madamanchi et al. (2004) to extract NOX-ROS data, verifyResponse with CoVe checks claims against 1566 citations, and runPythonAnalysis plots ROS levels from extracted datasets using matplotlib. GRADE grading scores evidence strength for NOX in vascular disease.

Synthesize & Write

Synthesis Agent detects gaps in NOX-endothelin crosstalk via contradiction flagging across Paravicini papers, generates exportMermaid diagrams of NOX activation pathways. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations integrates 10+ references, and latexCompile produces polished figures.

Use Cases

"Plot NOX-derived superoxide levels vs NO bioavailability in hypertension models from literature data."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas data extraction, matplotlib plotting) → researcher gets CSV-exported graphs with statistical fits.

"Draft LaTeX review section on NOX inhibitors in vascular ROS with citations."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Heumüller 2007, Lassègue 2012) + latexCompile → researcher gets compiled PDF section.

"Find GitHub repos analyzing NOX gene expression in vascular datasets."

Research Agent → paperExtractUrls (Touyz 2018) → Code Discovery → paperFindGithubRepo + githubRepoInspect → researcher gets inspected repo with RNA-seq analysis code.

Automated Workflows

Deep Research workflow scans 50+ NOX papers via searchPapers → citationGraph → structured report on isoform roles in ROS-NO crosstalk. DeepScan's 7-step chain verifies apocynin data (Heumüller 2007) with CoVe checkpoints and Python stats. Theorizer generates hypotheses on NOX4-endothelin interactions from Madamanchi (2004) and Touyz (2018).

Frequently Asked Questions

What defines NADPH oxidase NOX family in vascular ROS?

NOX1-5 and DUOX enzymes produce superoxide in vascular endothelium and smooth muscle, scavenging NO and promoting oxidative stress (Lassègue et al., 2012).

What are key methods to study vascular NOX?

Genetic knockouts, lucigenin assays for superoxide, and inhibitors like apocynin (antioxidant, not specific) assess NOX activity (Heumüller et al., 2007; Panday et al., 2014).

What are seminal papers on this topic?

Madamanchi et al. (2004; 1566 citations) links NOX-ROS to CVD; Lassègue et al. (2012; 750 citations) details cardiovascular NOX isoforms.

What open problems exist?

Isoform-selective inhibitors and real-time ROS-NO dynamics in vivo remain unresolved (Paravicini and Touyz, 2008; Touyz et al., 2018).

Research Nitric Oxide and Endothelin Effects with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching NADPH Oxidase NOX Family in Vascular ROS with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.